Posts

Showing posts from August, 2021

Is Glenmark Life Science Good Bet for Long-Term Investment?

Image
    Market Price: - 733.85 Glenmark Life Science list at 751 with just 4% premium on Indian Stock Exchange as on 06 August 2021. Glenmark Life Sciences initial public offering had received strong response from investors as the offer was subscribed 44.17 times during July 27-29, 2021. The Non-institutional investors reserved portion was subscribed 122.54 times, the qualified institutional buyers were subscribed 36.97 times and the retail portion received 14.63 times subscription. Due to downtrend in Pharma Sector, Glenmark Life Science listed at Just 4% Premium after getting good subscription.     Glenmark Life Science Limited Glenmark Life Sciences is an API arm of Glen Mark Pharma, a leading drug maker. They are one of the leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs).   Who They Are? They are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, they have establi...

IPO Season – Series 2

Image
Exxaro Tiles Limited Exxaro Tiles makes and sells vitrified floor tiles. The company started as a partnership firm in 2007-08 making frit, a raw material used in tile manufacturing, and evolved over the years into a manufacturer of vitrified tiles. It has two product categories – double charge vitrified tiles and glazed vitrified tiles. The products are marketed under the Exxaro brand and they are available in six sizes and in more than 1,000 designs. It also supplies wall tiles to certain dealers, outsourcing their manufacture. Exxaro has more than 2,000 dealers and its tiles were sold in 24 states and Union Territories in FY21. The tiles are also exported to over 12 countries including Poland, the United Arab Emirates, Italy and Bosnia. Exports contributed 13.88 percent of the company’s total revenue and they have increased at a CAGR of 47.92 percent during FY19-FY21.   My Point of View ·         Apply with listing gain and long ...

IPO Season Series: - 1

    IPO Season Series: - 1   Krsnaa Diagnostics Ltd. Krsnaa Diagnostics Limited is a large and differentiated diagnostic services provider. It provides a range of technology-enabled diagnostic service such as imaging (Including radiology), pathology/ clinical laboratory, teleradiology services to public and private hospitals, medical colleges, and community health centers across India. It is the fastest-growing diagnostic chain in india on multiple parameters. The company has an extensive network of integrated diagnostic chain in india on multiple parameters. The company has an extensive network of integrated diagnostic center across India primarily in non-metro and lower-tier cities and towns.   Krsnaa Diagnostics Key Details: ·         1000+ radiology centers and 500+ pathology centers. ·         More than 70,000 CT/MRI & 5 Lac X-rays per month. ·     ...